Viva Biotech Holdings (HKG: 1873)

Market Cap	1.29B
Revenue (ttm)	2.14B
Net Income (ttm)	-341.69K
Shares Out	2.14B
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	786,500
Open	0.600
Previous Close	0.620
Day's Range	0.590 - 0.610
52-Week Range	0.410 - 1.410
Beta	1.23
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Viva Biotech Holdings

Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical tec...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 2,077
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1873

Financial Performance

In 2023, Viva Biotech Holdings's revenue was 2.16 billion, a decrease of -9.42% compared to the previous year's 2.38 billion. Losses were -116.11 million, -78.03% less than in 2022.

Financial numbers in CNY